BCL2 and B-cell non-Hodgkin lymphoma: Furthermore, the increased detection of genetic aberrations frequently observed in B-cell lymphomas, including BCL2, BCL6, IGH, and MALT1 translocations, should promote the development of lymphoma gene panels for BALF in the era of next-generation sequencing.